Screener
Edwards Lifesciences EW EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's EBITDA?
- Edwards Lifesciences (EW) reported EBITDA of $518.5M in Q1 2026.
- How has Edwards Lifesciences's EBITDA changed year-over-year?
- Edwards Lifesciences's EBITDA increased by 20.2% year-over-year, from $431.4M to $518.5M.
- What is the long-term trend for Edwards Lifesciences's EBITDA?
- Over 4 years (2021 to 2025), Edwards Lifesciences's EBITDA has grown at a -6.1% compound annual growth rate (CAGR), from $1.83B to $1.42B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Edwards Lifesciences's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude